Connection
Cindy O'Bryant to Pyrazoles
This is a "connection" page, showing publications Cindy O'Bryant has written about Pyrazoles.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.382 |
|
|
|
-
O'Bryant CL, Wenger SD, Kim M, Thompson LA. Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer. Ann Pharmacother. 2013 Feb; 47(2):189-97.
Score: 0.322
-
Lam ET, O'Bryant CL, Basche M, Gustafson DL, Serkova N, Baron A, Holden SN, Dancey J, Eckhardt SG, Gore L. A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. Mol Cancer Ther. 2008 Dec; 7(12):3685-94.
Score: 0.060